Creatinine and creatine phosphokinase were both increased in 13% of patients with COVID-19 [9] while Wu et al. observed a change in the percentages of liver function biomarkers (ALB, GGT, AST, ALT, TBIL, and ALP) [10]. The gene discussed is GPT; the disease is COVID-19.